The results showed that SOCS1 and SOCS3 are overexpressed in primary GBM, and also demonstrate a relationship between SOCS3 expression and radiotherapy resistance acquisition, suggesting the utility of SOCS3 and its signal transduction pathway as a new source of therapeutic targets. This evidence concerns the gene SOCS1 and glioblastoma.